The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
2U INC COM 90214J101 39,254 2,594,620 SH   DFND 1 2,594,620 0 0
OVASCIENCE INC COM 69014Q101 21,935 2,392,034 SH   DFND 1 2,392,034 0 0
CERULEAN PHARMA INC COM 15708Q105 880 168,580 SH   DFND 1 168,580 0 0
VERASTEM INC COM 92337C104 10,785 1,190,358 SH   DFND 1 1,190,358 0 0
WIX COM LTD SHS M98068105 157,450 7,935,978 SH   DFND 1 7,935,978 0 0
CRITEO S A SPONS ADS 226718104 118,145 3,498,513 SH   DFND 1 3,498,513 0 0
ACCELERON PHARMA INC COM 00434H108 5,947 175,075 SH   DFND 1 175,075 0 0